Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 14,000 shares at $11.00 ($154K) on 2018-05-31, disclosed to the SEC on 2018-06-01.
Open-market sale of $154k ARWR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.00 | 1,400 | $15K | 10.0% |
| 2 | $11.00 | 12,600 | $139K | 90.0% |
| Total | $11.00 avg | 14,000 | $154K | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |